Malignant Biphasic Mesothelioma — Clinical Trials

MONDO:00061093 active·1 recruitingLast updated: Mar 15, 2026, 7:54 PM

Trial Landscape

Malignant Biphasic Mesothelioma has an emerging clinical trial program, driven by procedure and biological therapy.

Recruiting

Active Trials

By Approach

Procedure2

Biological Therapy2

Drug Treatment1

1 additional trials involve behavioral, dietary, diagnostic, or observational approaches.

By Phase

Phase 1

Phase 2

Sponsor Types

Academic/Other2NIH1

Trial Locations

United States3 trials

Trials often recruit across multiple countries, so totals exceed the trial count.

3 Trials

Phase 2Recruiting

NCT05647265

Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma

Sponsor:Alliance for Clinical Trials in Oncology

United StatesStarted: Nov 2024Est. completion: Dec 2026Updated: Mar 2026

Phase 2Active, Not Recruiting

NCT02399371

Pembrolizumab in Treating Patients With Malignant Mesothelioma

Sponsor:University of Chicago

United StatesStarted: Mar 2015Est. completion: Mar 2026Updated: Jun 2025

Phase 1Active, Not Recruiting

NCT03228537

Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant Mesothelioma

Sponsor:National Cancer Institute (NCI)

United StatesStarted: Jul 2018Est. completion: Sep 2026Updated: Nov 2025

Stay informed about clinical trials for Malignant Biphasic Mesothelioma.

Follow this disease to get updates when trials open, close, or change status.

Follow This Disease — Free

Already have an account? Sign in to manage your watchlists.

Data sourced from ClinicalTrials.gov via Kisho's automated pipeline. Trials refreshed every 4 hours for monitored diseases.

Last sync: March 15, 2026 at 7:54 PM